Page last updated: 2024-11-01
niclosamide and Multiple Primary Neoplasms
niclosamide has been researched along with Multiple Primary Neoplasms in 1 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| " Toxicities will be graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) v4." | 6.87 | Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial. ( Burock, S; Daum, S; Keilholz, U; Neumann, K; Stein, U; Walther, W, 2018) |
| " Toxicities will be graded according to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) v4." | 2.87 | Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial. ( Burock, S; Daum, S; Keilholz, U; Neumann, K; Stein, U; Walther, W, 2018) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Burock, S | 1 |
| Daum, S | 1 |
| Keilholz, U | 1 |
| Neumann, K | 1 |
| Walther, W | 1 |
| Stein, U | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Phase II Trial to Investigate the Safety and Efficacy of Orally Applied Niclosamide in Patients With Metachronous or Synchronous Metastases of a Colorectal Cancer Progressing After Therapy[NCT02519582] | Phase 2 | 37 participants (Anticipated) | Interventional | 2015-08-31 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for niclosamide and Multiple Primary Neoplasms